Company to Enter the $94 Billion European Clinical Device Market BOSTON, Oct. 14 (HSMN NewsFeed) — Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company has taken the initial steps to obtain the CE Mark for its Food and Dr…
Devices, Regulatory
Solos Endoscopy, MammoView

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Solos Endoscopy, Inc.’s FDA Approved MammoView(TM) Product Line to Obtain CE Mark”
Leave a Comment